Biocon Biologics features on ASIA IP ELITE List 2022
This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list
This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list
Kauliv provides reusable and disposable pen2 device options to cater to the global market demand.
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
The company is making its entry into the Hyderabad market through its unique asset-light business model
Dr. Mandaviya agreed to host the Stop TB Partnership’s 36th Board meeting on March 25-26, 2023 in Varanasi
The team will assist the State Health Authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures
ASG is accelerating its doctor-led mission to enhance the quality of care, deliver eye care for all, and improve quality of life across India.
The Group will continue to make proactive investments of its management resources in the life science business
For the half year ended September 30th, 2022 revenue from operations stood at Rs. 185.44 crore in H1 FY23, as against Rs. 219.89 crore in H1 FY22, a decrease of 15.67%
Subscribe To Our Newsletter & Stay Updated